Abstract: Embodiments of a method and system for engaging a patient include receiving a set of user inputs from the patient at an interaction engine associated with a companion robot; at the interaction engine, determining a patient model for the patient; at the interaction engine, determining patient goals for the patient; at the interaction engine, generating an interaction plan including a conversation component and an animation component, based on the patient model and the patient goals; and executing the interaction plan with the companion robot, thereby promoting engagement between the patient and the companion robot, in improving healthcare of the patient.

Abstract: Embodiments of a method and system for engaging a patient include receiving a set of user inputs from the patient at an interaction engine associated with a companion robot; at the interaction engine, determining a patient model for the patient; at the interaction engine, determining patient goals for the patient; at the interaction engine, generating an interaction plan including a conversation component and an animation component, based on the patient model and the patient goals; and executing the interaction plan with the companion robot, thereby promoting engagement between the patient and the companion robot, in improving healthcare of the patient.

Abstract: The technology relates to the use of a proteolytic enzyme, for example hyaluronidase, for the treatment of abnormal protein collection in a patient's lymphatic system. In addition, the present technology provides a composition and a combined preparation each comprising hyaluronidase and at least one further proteolytic enzyme, and a method of prevention and/or treating primary or secondary edema in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.